Skip to main content
Log in

Risk aversion and the value of diagnostic tests

  • Published:
Theory and Decision Aims and scope Submit manuscript

Abstract

Diagnostic tests allow better informed medical decisions when there is uncertainty about a patient’s health status and, therefore, about the desirability to undertake treatment. This paper studies the relation between the expected value of diagnostic information and a patient's risk aversion. We show that the ex ante value of diagnostic information increases with risk aversion for diseases with low prevalence, but decreases with risk aversion for diseases with high prevalence. On the other hand, the ex post value of diagnostic information always increases with the patient's degree of risk aversion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Notes

  1. See for instance Freixas and Kihlstrom (1984) or Willinger (1989). A summary of the determinants of the value of information is provided in Hilton (1981).

  2. See for example Sandmo (1971) and Ebert et al. (2018).

  3. Allowing for imperfect tests would complicate the analysis and requires using different concepts of risk aversion. We leave this for future research.

  4. Theorem 1 in Jewitt (1987, p. 75) is as follows: Let the distribution functions \(F\) and \(G\) cross exactly once, and suppose that \(G\) crosses \(F\) from below. It follows that \(\int u\mathrm{d}G\ge \int u\mathrm{d}F\) implies \(\int v\mathrm{d}G\ge \int v\mathrm{d}F\) whenever \(u\) and \(v\) are both increasing with \(v\) more risk averse than \(u\) in the sense of Arrow–Pratt.

References

  • Bleichrodt, H., & Pinto, J. L. (2005). The validity of QALYs under non-expected utility. The Economic Journal, 115(503), 533–550.

    Google Scholar 

  • Ebert, S., Nocetti, D., & Schlesinger, H. (2018). Greater mutual aggravation. Management Science, 64(6), 2809–2811.

    Google Scholar 

  • Eeckhoudt, L. (2002). Risk and medical decision making. Boston: Kluwer Academic Publishers.

    Google Scholar 

  • Eeckhoudt, L., Lebrun, T., & Sailly, J. C. (1984). The informative content of diagnostic tests: an economic analysis. Social Science and Medicine, 18(10), 873–880.

    Google Scholar 

  • Eeckhoudt, L., Lebrun, T., & Sailly, J. C. (1985). Risk-aversion and physicians medical decision-making. Journal of Health Economics, 4(3), 273–281.

    Google Scholar 

  • Eeckhoudt, L., Rey, B., & Schlesinger, H. (2007). A good sign for multivariate risk taking. Management Science, 53(1), 117–124.

    Google Scholar 

  • Felder, S., & Mayrhofer, T. (2014). Risk preferences: consequences for test and treatment thresholds and optimal cutoffs. Medical Decision Making, 34(1), 34–41.

    Google Scholar 

  • Freixas, X., & Kihlstrom, R. (1984). Risk aversion and information demand. In M. Boyer & R. Kihlstrom (Eds.), Bayesian Models of Economic Theory (pp. 93–104). Amsterdam: Elsevier.

    Google Scholar 

  • Gollier, C., & Pratt, J. W. (1996). Risk vulnerability and the tempering effect of background risk. Econometrica, 64(5), 1109–1123.

    Google Scholar 

  • Gould, J. (1974). Risk, stochastic preference, and the value of information. Journal of Economic Theory, 8, 64–84.

    Google Scholar 

  • Hilton, R. (1981). The determinants of information value: synthesizing some general results. Management Science, 27(1), 57–64.

    Google Scholar 

  • Jewitt, I. (1987). Risk aversion and the choice between risky prospects: the preservation of comparative statics results. Review of Economic Studies, 54, 73–85.

    Google Scholar 

  • Kőszegi, B. (2003). Health anxiety and patient behavior. Journal of Health Economics, 22(6), 1073–1084.

    Google Scholar 

  • Maccheroni, F., Marinacci, M., & Ruffino, D. (2013). Alpha as ambiguity: robust mean-variance portfolio analysis. Econometrica, 81(3), 1075–1113.

    Google Scholar 

  • McNeil, B. J., Weichselbaum, R., & Pauker, S. G. (1981). Tradeoffs between quality and quantity of life in laryngeal cancer. New England Journal of Medicine, 305, 982–987.

    Google Scholar 

  • Pauker, S., & Kassirer, J. (1980). The threshold approach to clinical decision making. New England Journal of Medicine, 302, 1109–1117.

    Google Scholar 

  • Pratt, J. W. (1964). Risk aversion in the small and in the large. Econometrica, 32, 122–136.

    Google Scholar 

  • Sandmo, A. (1971). On the theory of the competitive firm under price uncertainty. The American Economic Review, 61(1), 65–73.

    Google Scholar 

  • Stiggelbout, A. M., Kiebert, G. M., Kievit, J., Leer, J. W. H., Stoter, G., & De Haes, J. C. J. M. (1994). Utility assessment in cancer patients adjustment of time tradeoff scores for the utility of life years and comparison with standard gamble scores. Medical Decision Making, 14(1), 82–90.

    Google Scholar 

  • Willinger, M. (1989). Risk aversion and the value of information. The Journal of Risk and Insurance, 56(1), 104–112.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to David Crainich.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bleichrodt, H., Crainich, D., Eeckhoudt, L. et al. Risk aversion and the value of diagnostic tests. Theory Decis 89, 137–149 (2020). https://doi.org/10.1007/s11238-020-09750-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11238-020-09750-8

Keywords

Navigation